TreeWAS – Variant ID: rs17305086

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
D50.9 Iron deficiency anaemia, unspecified	0.257	0.743	0.000
D50 Iron deficiency anaemia	0.076	0.924	0.000
D50.0 Iron deficiency anaemia secondary to blood loss (chronic)	0.057	0.943	0.000
D50.1 Sideropenic dysphagia	0.055	0.945	0.000
D50.8 Other iron deficiency anaemias	0.023	0.977	0.000
N95.2 Postmenopausal atrophic vaginitis	0.019	0.981	0.000
D50-D53 Nutritional anaemias	0.018	0.982	0.000
Z88.6 Personal history of allergy to analgesic agent	0.000	0.982	0.018
H11.4 Other conjunctival vascular disorders and cysts	0.000	0.984	0.016
H11 Other disorders of conjunctiva	0.000	0.986	0.014
D53 Other nutritional anaemias	0.014	0.986	0.000
H11.8 Other specified disorders of conjunctiva	0.000	0.987	0.013
H11.1 Conjunctival degenerations and deposits	0.000	0.987	0.012
H11.3 Conjunctival haemorrhage	0.000	0.988	0.012
K81.9 Cholecystitis, unspecified	0.000	0.989	0.011
H11.0 Pterygium	0.000	0.989	0.011
K81.1 Chronic cholecystitis	0.000	0.989	0.011
H11.9 Disorder of conjunctiva, unspecified	0.000	0.989	0.011
D53.9 Nutritional anaemia, unspecified	0.011	0.989	0.000
K81 Cholecystitis	0.000	0.990	0.010
D53.8 Other specified nutritional anaemias	0.010	0.990	0.000
D53.2 Scorbutic anaemia	0.010	0.990	0.000
D53.1 Other megaloblastic anaemias, not elsewhere classified	0.010	0.990	0.000
D53.0 Protein deficiency anaemia	0.010	0.990	0.000
H11.2 Conjunctival scars	0.000	0.990	0.010
D52 Folate deficiency anaemia	0.009	0.990	0.000
D51 Vitamin B12 deficiency anaemia	0.010	0.990	0.000
D48.1 Connective and other soft tissue	0.000	0.990	0.010
K70.9 Alcoholic liver disease, unspecified	0.000	0.991	0.009
K81.0 Acute cholecystitis	0.000	0.991	0.009
S66.1 Injury of flexor muscle and tendon of other finger at wrist and hand level	0.009	0.991	0.000
D51.9 Vitamin B12 deficiency anaemia, unspecified	0.007	0.993	0.000
K81.8 Other cholecystitis	0.000	0.993	0.007
D52.8 Other folate deficiency anaemias	0.007	0.993	0.000
D52.1 Drug-induced folate deficiency anaemia	0.007	0.993	0.000
D52.0 Dietary folate deficiency anaemia	0.007	0.993	0.000
D51.8 Other vitamin B12 deficiency anaemias	0.007	0.993	0.000
D51.3 Other dietary vitamin B12 deficiency anaemia	0.007	0.993	0.000
D51.2 Transcobalamin II deficiency	0.007	0.993	0.000
D51.1 Vitamin B12 deficiency anaemia due to selective vitamin B12 malabsorption with proteinuria	0.007	0.993	0.000
S02.10 Fracture of base of skull (closed)	0.000	0.993	0.007
K75.9 Inflammatory liver disease, unspecified	0.000	0.993	0.007
Z48.8 Other specified surgical follow-up care	0.000	0.994	0.006
N95 Menopausal and other perimenopausal disorders	0.006	0.994	0.000
N95.3 States associated with artificial menopause	0.005	0.995	0.000
K70 Alcoholic liver disease	0.000	0.995	0.005
N20.2 Calculus of kidney with calculus of ureter	0.000	0.995	0.005
H50.9 Strabismus, unspecified	0.005	0.995	0.000
H10-H13 Disorders of conjunctiva	0.000	0.995	0.005
K70.4 Alcoholic hepatic failure	0.000	0.995	0.005
L50.9 Urticaria, unspecified	0.005	0.995	0.000
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)	0.005	0.995	0.000
M05.99 Seropositive rheumatoid arthritis, unspecified (Site unspecified)	0.005	0.995	0.000
M05.9 Seropositive rheumatoid arthritis, unspecified	0.005	0.995	0.000
N95.8 Other specified menopausal and perimenopausal disorders	0.005	0.995	0.000
S02.1 Fracture of base of skull	0.000	0.995	0.004
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.996	0.004
R80 Isolated proteinuria	0.000	0.996	0.004
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.996	0.004
M05.95 Seropositive rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.004	0.996	0.000
Z98.8 Other specified postsurgical states	0.000	0.996	0.004
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.996	0.004
T39.0 Salicylates	0.000	0.996	0.004
Y83.9 Surgical procedure, unspecified	0.004	0.996	0.000
N95.9 Menopausal and perimenopausal disorder, unspecified	0.004	0.996	0.000
K75 Other inflammatory liver diseases	0.000	0.996	0.004
K70.3 Alcoholic cirrhosis of liver	0.000	0.996	0.004
K70.2 Alcoholic fibrosis and sclerosis of liver	0.000	0.996	0.004
K70.0 Alcoholic fatty liver	0.000	0.996	0.004
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.996	0.004
H13 Disorders of conjunctiva in diseases classified elsewhere	0.000	0.996	0.004
R82.8 Abnormal findings on cytological and histological examination of urine	0.000	0.996	0.004
R82 Other abnormal findings in urine	0.000	0.996	0.004
M05.96 Seropositive rheumatoid arthritis, unspecified (Lower leg)	0.004	0.996	0.000
R82.7 Abnormal findings on microbiological examination of urine	0.000	0.996	0.004
D52.9 Folate deficiency anaemia, unspecified	0.003	0.996	0.001
N95.1 Menopausal and female climacteric states	0.004	0.996	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.996	0.004
M05.94 Seropositive rheumatoid arthritis, unspecified (Hand)	0.003	0.996	0.000
R80-R82 Abnormal findings on examination of urine, without diagnosis	0.000	0.996	0.004
M05.98 Seropositive rheumatoid arthritis, unspecified (Other)	0.003	0.996	0.000
M05.93 Seropositive rheumatoid arthritis, unspecified (Forearm)	0.003	0.996	0.000
M05.92 Seropositive rheumatoid arthritis, unspecified (Upper arm)	0.003	0.996	0.000
M05.91 Seropositive rheumatoid arthritis, unspecified (Shoulder region)	0.003	0.996	0.000
S02.11 Fracture of base of skull (open)	0.000	0.996	0.003
M05.97 Seropositive rheumatoid arthritis, unspecified (Ankle and foot)	0.003	0.997	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.997	0.003
R81 Glycosuria	0.000	0.997	0.003
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.997	0.003
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.997	0.003
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.997	0.003
T39.4 Antirheumatics, not elsewhere classified	0.000	0.997	0.003
T39.2 Pyrazolone derivatives	0.000	0.997	0.003
K70-K77 Diseases of liver	0.000	0.997	0.003
K75.0 Abscess of liver	0.000	0.997	0.003
K73 Chronic hepatitis, not elsewhere classified	0.000	0.997	0.003
D35.1 Parathyroid gland	0.003	0.997	0.000
T46.1 Calcium-channel blockers	0.000	0.997	0.003
K75.2 Nonspecific reactive hepatitis	0.000	0.997	0.003
K75.1 Phlebitis of portal vein	0.000	0.997	0.003
H10 Conjunctivitis	0.000	0.997	0.003
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.997	0.003
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.997	0.003
K75.3 Granulomatous hepatitis, not elsewhere classified	0.000	0.997	0.003
K75.4 Autoimmune hepatitis	0.000	0.997	0.003
T36 Poisoning by systemic antibiotics	0.000	0.997	0.003
H13.8 Other disorders of conjunctiva in diseases classified elsewhere	0.000	0.997	0.003
H13.3 Ocular pemphigoid	0.000	0.997	0.003
H13.2 Conjunctivitis in other diseases classified elsewhere	0.000	0.997	0.003
H13.1 Conjunctivitis in infectious and parasitic diseases classified elsewhere	0.000	0.997	0.003
H13.0 Filarial infection of conjunctiva	0.000	0.997	0.003
G12.2 Motor neuron disease	0.003	0.997	0.000
K73.2 Chronic active hepatitis, not elsewhere classified	0.000	0.997	0.003
R82.6 Abnormal urine levels of substances chiefly nonmedicinal as to source	0.000	0.997	0.003
R82.5 Elevated urine levels of drugs, medicaments and biological substances	0.000	0.997	0.003
R82.3 Haemoglobinuria	0.000	0.997	0.003
R82.2 Biliuria	0.000	0.997	0.003
R82.1 Myoglobinuria	0.000	0.997	0.003
R82.0 Chyluria	0.000	0.997	0.003
T45.0 Antiallergic and antiemetic drugs	0.000	0.997	0.003
K73.9 Chronic hepatitis, unspecified	0.000	0.997	0.003
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.997	0.003
D69.3 Idiopathic thrombocytopenic purpura	0.003	0.997	0.000
D10.3 Other and unspecified parts of mouth	0.000	0.997	0.003
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.997	0.003
F31.9 Bipolar affective disorder, unspecified	0.003	0.997	0.000
R82.9 Other and unspecified abnormal finding in urine	0.000	0.997	0.003
T36.0 Penicillins	0.000	0.997	0.003
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.997	0.003
N60.8 Other benign mammary dysplasias	0.000	0.997	0.003
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency	0.003	0.997	0.000
G56.2 Lesion of ulnar nerve	0.000	0.997	0.003
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.997	0.003
M79.10 Myalgia (Multiple sites)	0.003	0.997	0.000
S02.60 Fracture of mandible (closed)	0.000	0.997	0.003
D69.5 Secondary thrombocytopenia	0.003	0.997	0.000
D69 Purpura and other haemorrhagic conditions	0.003	0.997	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.997	0.003
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.997	0.003
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.997	0.003
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.997	0.003
K70.1 Alcoholic hepatitis	0.000	0.997	0.002
T38.9 Other and unspecified hormone antagonists	0.000	0.997	0.002
T38.7 Androgens and anabolic congeners	0.000	0.997	0.002
T38.5 Other oestrogens and progestogens	0.000	0.997	0.002
T38.4 Oral contraceptives	0.000	0.997	0.002
T38.2 Antithyroid drugs	0.000	0.997	0.002
T38.0 Glucocorticoids and synthetic analogues	0.000	0.997	0.002
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.997	0.002
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.997	0.002
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.002
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.002
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.002
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.997	0.002
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.997	0.002
T44.0 Anticholinesterase agents	0.000	0.997	0.002
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.997	0.003
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.997	0.003
T46.7 Peripheral vasodilators	0.000	0.997	0.003
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.997	0.003
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.997	0.003
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.997	0.003
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.997	0.003
K77 Liver disorders in diseases classified elsewhere	0.000	0.997	0.003
K71 Toxic liver disease	0.000	0.997	0.003
N60.2 Fibroadenosis of breast	0.000	0.997	0.003
S02.6 Fracture of mandible	0.000	0.997	0.003
S02 Fracture of skull and facial bones	0.000	0.997	0.003
D69.0 Allergic purpura	0.003	0.997	0.000
K73.8 Other chronic hepatitis, not elsewhere classified	0.000	0.997	0.002
K73.1 Chronic lobular hepatitis, not elsewhere classified	0.000	0.997	0.002
K73.0 Chronic persistent hepatitis, not elsewhere classified	0.000	0.997	0.002
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.997	0.002
S02.00 Fracture of vault of skull (closed)	0.000	0.997	0.003
S02.0 Fracture of vault of skull	0.000	0.997	0.003
H10.8 Other conjunctivitis	0.000	0.997	0.002
H10.5 Blepharoconjunctivitis	0.000	0.997	0.002
H10.3 Acute conjunctivitis, unspecified	0.000	0.997	0.002
H10.2 Other acute conjunctivitis	0.000	0.997	0.002
H10.1 Acute atopic conjunctivitis	0.000	0.997	0.002
H10.0 Mucopurulent conjunctivitis	0.000	0.997	0.002
N18.0 End-stage renal disease	0.000	0.997	0.003
O26.9 Pregnancy-related condition, unspecified	0.003	0.997	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.997	0.002
T45.8 Other primarily systemic and haematological agents	0.000	0.997	0.002
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.997	0.002
T45.6 Fibrinolysis-affecting drugs	0.000	0.997	0.002
T45.4 Iron and its compounds	0.000	0.997	0.002
T45.3 Enzymes, not elsewhere classified	0.000	0.997	0.002
T45.2 Vitamins, not elsewhere classified	0.000	0.997	0.002
N60.1 Diffuse cystic mastopathy	0.000	0.997	0.003
T38.1 Thyroid hormones and substitutes	0.000	0.997	0.002
Z48 Other surgical follow-up care	0.000	0.997	0.003
N60 Benign mammary dysplasia	0.000	0.997	0.003
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.997	0.002
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.998	0.002
G24.9 Dystonia, unspecified	0.000	0.998	0.002
T40.4 Other synthetic narcotics	0.002	0.998	0.000
R82.4 Acetonuria	0.000	0.998	0.002
T36.9 Systemic antibiotic, unspecified	0.000	0.998	0.002
T36.8 Other systemic antibiotics	0.000	0.998	0.002
T36.7 Antifungal antibiotics, systemically used	0.000	0.998	0.002
T36.6 Rifamycins	0.000	0.998	0.002
T36.5 Aminoglycosides	0.000	0.998	0.002
T36.4 Tetracyclines	0.000	0.998	0.002
T36.3 Macrolides	0.000	0.998	0.002
T36.2 Chloramphenicol group	0.000	0.998	0.002
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.998	0.002
Z48.0 Attention to surgical dressings and sutures	0.000	0.998	0.002
T45.5 Anticoagulants	0.000	0.998	0.002
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.998	0.002
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.998	0.002
T47.7 Emetics	0.000	0.998	0.002
T47.6 Antidiarrhoeal drugs	0.000	0.998	0.002
T47.5 Digestants	0.000	0.998	0.002
T47.4 Other laxatives	0.000	0.998	0.002
T47.3 Saline and osmotic laxatives	0.000	0.998	0.002
T47.2 Stimulant laxatives	0.000	0.998	0.002
T47.0 Histamine H(2)-receptor antagonists	0.000	0.998	0.002
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.000	0.998	0.002
K72 Hepatic failure, not elsewhere classified	0.000	0.998	0.002
D48.7 Other specified sites	0.000	0.998	0.002
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.998	0.002
K74.5 Biliary cirrhosis, unspecified	0.000	0.998	0.002
L02.9 Cutaneous abscess, furuncle and carbuncle, unspecified	0.002	0.998	0.000
N60.3 Fibrosclerosis of breast	0.000	0.998	0.002
N64.1 Fat necrosis of breast	0.000	0.998	0.002
S02.3 Fracture of orbital floor	0.000	0.998	0.002
Z13.0 Special screening examination for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.000	0.998	0.002
M05 Seropositive rheumatoid arthritis	0.002	0.998	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.001	0.998	0.002
H10.4 Chronic conjunctivitis	0.000	0.998	0.002
Z08.7 Follow-up examination after combined treatment for malignant neoplasm	0.002	0.998	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.998	0.002
T42.0 Hydantoin derivatives	0.000	0.998	0.002
K74 Fibrosis and cirrhosis of liver	0.000	0.998	0.002
S02.5 Fracture of tooth	0.000	0.998	0.002
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.998	0.002
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.998	0.002
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.998	0.002
T37.5 Antiviral drugs	0.000	0.998	0.002
T37.4 Anthelminthics	0.000	0.998	0.002
T37.3 Other antiprotozoal drugs	0.000	0.998	0.002
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.998	0.002
T37.1 Antimycobacterial drugs	0.000	0.998	0.002
T37.0 Sulphonamides	0.000	0.998	0.002
D69.8 Other specified haemorrhagic conditions	0.002	0.998	0.000
D69.2 Other nonthrombocytopenic purpura	0.002	0.998	0.000
D69.1 Qualitative platelet defects	0.002	0.998	0.000
S02.9 Fracture of skull and facial bones, part unspecified	0.000	0.998	0.002
T41.5 Therapeutic gases	0.000	0.998	0.002
T41.4 Anaesthetic, unspecified	0.000	0.998	0.002
T41.3 Local anaesthetics	0.000	0.998	0.002
T41.2 Other and unspecified general anaesthetics	0.000	0.998	0.002
T41.1 Intravenous anaesthetics	0.000	0.998	0.002
T41.0 Inhaled anaesthetics	0.000	0.998	0.002
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.998	0.002
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.998	0.002
T48.5 Anti-common-cold drugs	0.000	0.998	0.002
T48.4 Expectorants	0.000	0.998	0.002
T48.3 Antitussives	0.000	0.998	0.002
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.998	0.002
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.998	0.002
T48.0 Oxytocic drugs	0.000	0.998	0.002
T49.9 Topical agent, unspecified	0.000	0.998	0.002
T49.8 Other topical agents	0.000	0.998	0.002
T49.7 Dental drugs, topically applied	0.000	0.998	0.002
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.998	0.002
T49.5 Ophthalmological drugs and preparations	0.000	0.998	0.002
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.998	0.002
T49.3 Emollients, demulcents and protectants	0.000	0.998	0.002
T49.2 Local astringents and local detergents	0.000	0.998	0.002
T49.1 Antipruritics	0.000	0.998	0.002
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.998	0.002
S02.61 Fracture of mandible (open)	0.000	0.998	0.002
K65.9 Peritonitis, unspecified	0.000	0.998	0.002
K71.9 Toxic liver disease, unspecified	0.000	0.998	0.002
K71.8 Toxic liver disease with other disorders of liver	0.000	0.998	0.002
K71.7 Toxic liver disease with fibrosis and cirrhosis of liver	0.000	0.998	0.002
K71.6 Toxic liver disease with hepatitis, not elsewhere classified	0.000	0.998	0.002
K71.5 Toxic liver disease with chronic active hepatitis	0.000	0.998	0.002
K71.4 Toxic liver disease with chronic lobular hepatitis	0.000	0.998	0.002
K71.3 Toxic liver disease with chronic persistent hepatitis	0.000	0.998	0.002
K71.2 Toxic liver disease with acute hepatitis	0.000	0.998	0.002
K71.1 Toxic liver disease with hepatic necrosis	0.000	0.998	0.002
K71.0 Toxic liver disease with cholestasis	0.000	0.998	0.002
K77.8 Liver disorders in other diseases classified elsewhere	0.000	0.998	0.002
K77.0 Liver disorders in infectious and parasitic diseases classified elsewhere	0.000	0.998	0.002
D69.4 Other primary thrombocytopenia	0.002	0.998	0.000
H10.9 Conjunctivitis, unspecified	0.000	0.998	0.002
S02.01 Fracture of vault of skull (open)	0.000	0.998	0.002
S02.30 Fracture of orbital floor (closed)	0.000	0.998	0.002
T42.4 Benzodiazepines	0.002	0.998	0.000
N39.9 Disorder of urinary system, unspecified	0.000	0.998	0.002
T42.1 Iminostilbenes	0.000	0.998	0.002
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.998	0.002
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.998	0.002
T42.3 Barbiturates	0.000	0.998	0.002
T42.2 Succinimides and oxazolidinediones	0.000	0.998	0.002
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.002	0.998	0.000
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.002	0.998	0.000
M48.07 Spinal stenosis (Lumbosacral region)	0.000	0.998	0.002
N77.1 Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
M75.5 Bursitis of shoulder	0.000	0.998	0.002
D35.0 Adrenal gland	0.002	0.998	0.000
N28.9 Disorder of kidney and ureter, unspecified	0.000	0.998	0.002
S02.7 Multiple fractures involving skull and facial bones	0.000	0.998	0.002
D67 Hereditary factor IX deficiency	0.002	0.998	0.000
D65 Disseminated intravascular coagulation [defibrination syndrome]	0.002	0.998	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
S02.50 Fracture of tooth (closed)	0.000	0.998	0.002
C26.0 Intestinal tract, part unspecified	0.002	0.998	0.000
D48.4 Peritoneum	0.000	0.998	0.002
D48.3 Retroperitoneum	0.000	0.998	0.002
D48.2 Peripheral nerves and autonomic nervous system	0.000	0.998	0.002
D48.9 Neoplasms of uncertain or unknown behaviour, unspecified	0.000	0.998	0.002
K72.1 Chronic hepatic failure	0.000	0.998	0.002
D55-D59 Haemolytic anaemias	0.002	0.998	0.000
S02.31 Fracture of orbital floor (open)	0.000	0.998	0.002
D69.9 Haemorrhagic condition, unspecified	0.002	0.998	0.000
S02.90 Fracture of skull and facial bones, part unspecified (closed)	0.000	0.998	0.002
M05.8 Other seropositive rheumatoid arthritis	0.002	0.998	0.000
M05.3 Rheumatoid arthritis with involvement of other organs and systems	0.002	0.998	0.000
M05.2 Rheumatoid vasculitis	0.002	0.998	0.000
M05.1 Rheumatoid lung disease	0.002	0.998	0.000
M05.0 Felty's syndrome	0.002	0.998	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.001	0.998	0.001
T40.8 Lysergide [LSD]	0.001	0.998	0.001
T40.7 Cannabis (derivatives)	0.001	0.998	0.001
T40.5 Cocaine	0.001	0.998	0.001
T40.3 Methadone	0.001	0.998	0.001
T40.1 Heroin	0.001	0.998	0.001
T40.0 Opium	0.001	0.998	0.001
D69.6 Thrombocytopenia, unspecified	0.002	0.998	0.000
G25.8 Other specified extrapyramidal and movement disorders	0.000	0.998	0.002
S02.51 Fracture of tooth (open)	0.000	0.998	0.002
C32.0 Glottis	0.002	0.998	0.000
K74.4 Secondary biliary cirrhosis	0.000	0.998	0.002
K74.2 Hepatic fibrosis with hepatic sclerosis	0.000	0.998	0.002
K74.1 Hepatic sclerosis	0.000	0.998	0.002
N60.9 Benign mammary dysplasia, unspecified	0.000	0.998	0.002
N60.4 Mammary duct ectasia	0.000	0.998	0.002
T40.2 Other opioids	0.000	0.998	0.002
K72.0 Acute and subacute hepatic failure	0.000	0.998	0.002
S02.91 Fracture of skull and facial bones, part unspecified (open)	0.000	0.998	0.002
M25.64 Stiffness of joint, not elsewhere classified (Hand)	0.002	0.998	0.000
S22.40 Multiple fractures of ribs (closed)	0.000	0.998	0.002
C67.9 Bladder, unspecified	0.002	0.998	0.000
H02.3 Blepharochalasis	0.002	0.998	0.000
G12 Spinal muscular atrophy and related syndromes	0.002	0.998	0.000
D59 Acquired haemolytic anaemia	0.002	0.998	0.000
O62.2 Other uterine inertia	0.000	0.998	0.002
N60.0 Solitary cyst of breast	0.000	0.998	0.002
S02.8 Fractures of other skull and facial bones	0.000	0.998	0.002
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.001	0.998	0.001
M25.67 Stiffness of joint, not elsewhere classified (Ankle and foot)	0.002	0.998	0.000
N42.8 Other specified disorders of prostate	0.000	0.998	0.002
D59.1 Other autoimmune haemolytic anaemias	0.002	0.998	0.000
D58 Other hereditary haemolytic anaemias	0.002	0.998	0.000
S02.4 Fracture of malar and maxillary bones	0.000	0.998	0.002
S02.2 Fracture of nasal bones	0.000	0.998	0.002
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
S02.71 Multiple fractures involving skull and facial bones (open)	0.000	0.998	0.001
D59.0 Drug-induced autoimmune haemolytic anaemia	0.002	0.998	0.000
T50.8 Diagnostic agents	0.000	0.998	0.002
T50.7 Analeptics and opioid receptor antagonists	0.000	0.998	0.002
T50.5 Appetite depressants	0.000	0.998	0.002
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.998	0.002
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.998	0.002
T50.1 Loop [high-ceiling] diuretics	0.000	0.998	0.002
T50.0 Mineralocorticoids and their antagonists	0.000	0.998	0.002
D57 Sickle-cell disorders	0.002	0.998	0.000
D56 Thalassaemia	0.002	0.998	0.000
D55 Anaemia due to enzyme disorders	0.002	0.998	0.000
M05.09 Felty's syndrome (Site unspecified)	0.001	0.998	0.000
M05.08 Felty's syndrome (Other)	0.001	0.998	0.000
M05.07 Felty's syndrome (Ankle and foot)	0.001	0.998	0.000
M05.06 Felty's syndrome (Lower leg)	0.001	0.998	0.000
M05.05 Felty's syndrome (Pelvic region and thigh)	0.001	0.998	0.000
M05.04 Felty's syndrome (Hand)	0.001	0.998	0.000
M05.03 Felty's syndrome (Forearm)	0.001	0.998	0.000
M05.02 Felty's syndrome (Upper arm)	0.001	0.998	0.000
M05.01 Felty's syndrome (Shoulder region)	0.001	0.998	0.000
M05.00 Felty's syndrome (Multiple sites)	0.001	0.998	0.000
M05.19 Rheumatoid lung disease (Site unspecified)	0.001	0.998	0.000
M05.18 Rheumatoid lung disease (Other)	0.001	0.998	0.000
M05.17 Rheumatoid lung disease (Ankle and foot)	0.001	0.998	0.000
M05.16 Rheumatoid lung disease (Lower leg)	0.001	0.998	0.000
M05.15 Rheumatoid lung disease (Pelvic region and thigh)	0.001	0.998	0.000
M05.14 Rheumatoid lung disease (Hand)	0.001	0.998	0.000
M05.13 Rheumatoid lung disease (Forearm)	0.001	0.998	0.000
M05.12 Rheumatoid lung disease (Upper arm)	0.001	0.998	0.000
M05.11 Rheumatoid lung disease (Shoulder region)	0.001	0.998	0.000
M05.10 Rheumatoid lung disease (Multiple sites)	0.001	0.998	0.000
M05.29 Rheumatoid vasculitis (Site unspecified)	0.001	0.998	0.000
M05.28 Rheumatoid vasculitis (Other)	0.001	0.998	0.000
M05.27 Rheumatoid vasculitis (Ankle and foot)	0.001	0.998	0.000
M05.26 Rheumatoid vasculitis (Lower leg)	0.001	0.998	0.000
M05.25 Rheumatoid vasculitis (Pelvic region and thigh)	0.001	0.998	0.000
M05.24 Rheumatoid vasculitis (Hand)	0.001	0.998	0.000
M05.23 Rheumatoid vasculitis (Forearm)	0.001	0.998	0.000
M05.22 Rheumatoid vasculitis (Upper arm)	0.001	0.998	0.000
M05.21 Rheumatoid vasculitis (Shoulder region)	0.001	0.998	0.000
M05.20 Rheumatoid vasculitis (Multiple sites)	0.001	0.998	0.000
M05.39 Rheumatoid arthritis with involvement of other organs and systems (Site unspecified)	0.001	0.998	0.000
M05.38 Rheumatoid arthritis with involvement of other organs and systems (Other)	0.001	0.998	0.000
M05.37 Rheumatoid arthritis with involvement of other organs and systems (Ankle and foot)	0.001	0.998	0.000
M05.36 Rheumatoid arthritis with involvement of other organs and systems (Lower leg)	0.001	0.998	0.000
M05.35 Rheumatoid arthritis with involvement of other organs and systems (Pelvic region and thigh)	0.001	0.998	0.000
M05.34 Rheumatoid arthritis with involvement of other organs and systems (Hand)	0.001	0.998	0.000
M05.33 Rheumatoid arthritis with involvement of other organs and systems (Forearm)	0.001	0.998	0.000
M05.32 Rheumatoid arthritis with involvement of other organs and systems (Upper arm)	0.001	0.998	0.000
M05.31 Rheumatoid arthritis with involvement of other organs and systems (Shoulder region)	0.001	0.998	0.000
M05.30 Rheumatoid arthritis with involvement of other organs and systems (Multiple sites)	0.001	0.998	0.000
M05.89 Other seropositive rheumatoid arthritis (Site unspecified)	0.001	0.998	0.000
M05.88 Other seropositive rheumatoid arthritis (Other)	0.001	0.998	0.000
M05.87 Other seropositive rheumatoid arthritis (Ankle and foot)	0.001	0.998	0.000
M05.86 Other seropositive rheumatoid arthritis (Lower leg)	0.001	0.998	0.000
M05.85 Other seropositive rheumatoid arthritis (Pelvic region and thigh)	0.001	0.998	0.000
M05.84 Other seropositive rheumatoid arthritis (Hand)	0.001	0.998	0.000
M05.83 Other seropositive rheumatoid arthritis (Forearm)	0.001	0.998	0.000
M05.82 Other seropositive rheumatoid arthritis (Upper arm)	0.001	0.998	0.000
M05.81 Other seropositive rheumatoid arthritis (Shoulder region)	0.001	0.998	0.000
M05.80 Other seropositive rheumatoid arthritis (Multiple sites)	0.001	0.998	0.000
N80.9 Endometriosis, unspecified	0.002	0.998	0.000
O62.4 Hypertonic, incoordinate and prolonged uterine contractions	0.000	0.998	0.002
T40.6 Other and unspecified narcotics	0.001	0.998	0.001
T50.4 Drugs affecting uric acid metabolism	0.000	0.998	0.001
K72.9 Hepatic failure, unspecified	0.000	0.998	0.002
Q89.2 Congenital malformations of other endocrine glands	0.002	0.998	0.000
S91.3 Open wound of other parts of foot	0.000	0.998	0.002
T43.2 Other and unspecified antidepressants	0.000	0.998	0.002
M23.32 Other meniscus derangements (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.002	0.998	0.000
N64.9 Disorder of breast, unspecified	0.000	0.998	0.002
L50 Urticaria	0.002	0.998	0.000
M06.00 Seronegative rheumatoid arthritis (Multiple sites)	0.002	0.998	0.000
S92.20 Fracture of other tarsal bone(s) (closed)	0.002	0.998	0.000
T43.6 Psychostimulants with abuse potential	0.000	0.998	0.002
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.998	0.001
M41.94 Scoliosis, unspecified (Thoracic region)	0.002	0.998	0.000
H47.3 Other disorders of optic disk	0.002	0.998	0.000
K75.8 Other specified inflammatory liver diseases	0.000	0.998	0.001
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.998	0.002
X49.9 Unspecified place	0.000	0.998	0.002
D35 Benign neoplasm of other and unspecified endocrine glands	0.002	0.998	0.000
E46 Unspecified protein-energy malnutrition	0.000	0.998	0.002
M80.98 Unspecified osteoporosis with pathological fracture (Other)	0.000	0.998	0.002
D59.8 Other acquired haemolytic anaemias	0.001	0.998	0.000
D59.6 Haemoglobinuria due to haemolysis from other external causes	0.001	0.998	0.000
D59.5 Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]	0.001	0.998	0.000
D59.4 Other nonautoimmune haemolytic anaemias	0.001	0.998	0.000
D59.3 Haemolytic-uraemic syndrome	0.001	0.998	0.000
D59.2 Drug-induced nonautoimmune haemolytic anaemia	0.001	0.998	0.000
G12.9 Spinal muscular atrophy, unspecified	0.001	0.998	0.000
G12.8 Other spinal muscular atrophies and related syndromes	0.001	0.998	0.000
G12.1 Other inherited spinal muscular atrophy	0.001	0.998	0.000
G12.0 Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]	0.001	0.998	0.000
M25.6 Stiffness of joint, not elsewhere classified	0.002	0.998	0.000
M25.66 Stiffness of joint, not elsewhere classified (Lower leg)	0.002	0.998	0.000
D48.0 Bone and articular cartilage	0.000	0.998	0.001
D58.2 Other haemoglobinopathies	0.001	0.998	0.000
D58.0 Hereditary spherocytosis	0.001	0.998	0.000
M25.63 Stiffness of joint, not elsewhere classified (Forearm)	0.001	0.998	0.000
S02.81 Fractures of other skull and facial bones (open)	0.000	0.998	0.001
D56.1 Beta thalassaemia	0.001	0.998	0.000
H50.5 Heterophoria	0.001	0.998	0.000
O62.1 Secondary uterine inertia	0.000	0.998	0.001
K74.6 Other and unspecified cirrhosis of liver	0.000	0.998	0.002
S02.70 Multiple fractures involving skull and facial bones (closed)	0.000	0.998	0.001
D58.8 Other specified hereditary haemolytic anaemias	0.001	0.998	0.000
D58.1 Hereditary elliptocytosis	0.001	0.998	0.000
K74.3 Primary biliary cirrhosis	0.000	0.998	0.001
R29.6 Tendency to fall, not elsewhere classified	0.000	0.998	0.002
T43.9 Psychotropic drug, unspecified	0.000	0.998	0.001
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.998	0.001
M25.68 Stiffness of joint, not elsewhere classified (Other)	0.001	0.998	0.000
S02.41 Fracture of malar and maxillary bones (open)	0.000	0.998	0.001
B35.1 Tinea unguium	0.001	0.998	0.000
K74.0 Hepatic fibrosis	0.000	0.998	0.001
D55.9 Anaemia due to enzyme disorder, unspecified	0.001	0.999	0.000
D55.8 Other anaemias due to enzyme disorders	0.001	0.999	0.000
D55.3 Anaemia due to disorders of nucleotide metabolism	0.001	0.999	0.000
D55.2 Anaemia due to disorders of glycolytic enzymes	0.001	0.999	0.000
D55.1 Anaemia due to other disorders of glutathione metabolism	0.001	0.999	0.000
D55.0 Anaemia due to glucose-6-phosphate dehydrogenase [G6PD] deficiency	0.001	0.999	0.000
D56.9 Thalassaemia, unspecified	0.001	0.999	0.000
D56.8 Other thalassaemias	0.001	0.999	0.000
D56.4 Hereditary persistence of foetal haemoglobin [HPFH]	0.001	0.999	0.000
D56.2 Delta-beta thalassaemia	0.001	0.999	0.000
D56.0 Alpha thalassaemia	0.001	0.999	0.000
D57.8 Other sickle-cell disorders	0.001	0.999	0.000
D57.3 Sickle-cell trait	0.001	0.999	0.000
D57.2 Double heterozygous sickling disorders	0.001	0.999	0.000
D57.1 Sickle-cell anaemia without crisis	0.001	0.999	0.000
D57.0 Sickle-cell anaemia with crisis	0.001	0.999	0.000
O62.3 Precipitate labour	0.000	0.999	0.001
D48.5 Skin	0.000	0.999	0.001
L89.2 Stage III decubitus ulcer	0.000	0.999	0.001
O62 Abnormalities of forces of labour	0.000	0.999	0.001
M25.60 Stiffness of joint, not elsewhere classified (Multiple sites)	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations